SIRT7 and neoplasm: Interestingly, recent studies elucidating the expression profiles of sirtuins in PDAC revealed that low levels of nuclear SIRT7 correlate with more aggressive tumor phenotypes and poorer patient outcomes, thus establishing it as a significant biomarker for disease prognosis.